• Cholesterol Impairs Intracellular Trafficking of Lipid Nanop

  2026-05-27

  This study reveals that elevated cholesterol content in lipid nanoparticles (LNPs) impedes their intracellular trafficking, leading to reduced delivery efficiency of nucleic acid cargo. These findings provide mechanistic insight into LNP design parameters critical for nucleic acid therapeutics and highlight the importance of optimizing lipid composition for efficient endosomal escape.

• Unraveling M-CSF Biology: Strategic Guidance for Translation

  2026-05-26

  This thought-leadership article bridges mechanistic breakthroughs in macrophage biology—specifically the M-CSF/c-fms axis and its role in fibrosis and tumor immunity—with actionable strategies for translational researchers. By integrating recent molecular insights, including the IGF2BP1/THBS1/TLR4 axis in pulmonary fibrosis, and benchmarking the new APExBIO Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag, it offers protocol-level guidance, contextualizes competitive reagents, and outlines the translational horizon for fibrosis and immuno-oncology.

• MHY1485: Advanced mTOR Activation for Autophagy Assay Innova

  2026-05-26

  Explore MHY1485 as a powerful mTOR activator uniquely suited for autophagy assays and ovarian follicle development research. This in-depth analysis reveals mechanistic insights and practical protocols that distinguish MHY1485 from other modulators, making it essential for advanced cell biology studies.

• Decoding Lysis Buffer Efficacy in Mouse Tail Genotyping Kits

  2026-05-25

  Discover how lysis buffer, a key rapid genotyping kit component, reshapes the precision and integrity of genomic DNA release from mouse tail samples. This article explores advanced assay design and cross-links to cancer research insights, offering a unique perspective for genetic analysis workflows.

• Dual Recombinase Lineage Tracing Refutes Neo-oogenesis in Mi

  2026-05-25

  A recent study by Xie, Zhou, and Zheng employs a dual recombinase-mediated genetic tracing system to rigorously test the existence of postnatal neo-oogenesis in mice. Their findings provide robust genetic evidence that new oocytes are not generated after birth, even following chemically induced ovarian injury, refining experimental models in reproductive biology.

• Eliminating Pollen Spectral Interference in EEM Fluorescence

  2026-05-24

  Zhang et al. (2024) present a robust machine learning approach to accurately distinguish hazardous bioaerosols by addressing the significant spectral interference caused by pollen in excitation–emission matrix (EEM) fluorescence spectroscopy. Their integration of advanced spectral preprocessing and random forest classification improves hazardous substance detection, establishing a new methodological benchmark for bioaerosol monitoring.

• IGF2BP1-m6A-THBS1 Axis Drives Macrophage Fibrosis in Lungs

  2026-05-23

  This study uncovers how the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA in macrophages, enhancing glycolytic metabolism and M2 polarization through a TLR4-dependent pathway. These findings provide a mechanistic link between RNA modification, macrophage metabolic reprogramming, and fibrotic progression, suggesting new therapeutic targets for lung fibrosis.

• Smurf1 Downregulation Sensitizes Colorectal Cancer to Cispla

  2026-05-22

  This study demonstrates that low expression of Smurf1 significantly enhances the chemosensitivity of colorectal cancer (CRC) to gemcitabine and cisplatin in both cell and patient-derived xenograft models. The findings provide new mechanistic insight for overcoming chemotherapy resistance in CRC by targeting Smurf1, with direct implications for translational oncology research.

• Tamoxifen in Research: Applied Workflows and CreER Innovatio

  2026-05-22

  Tamoxifen stands out as a selective estrogen receptor modulator pivotal for CreER-mediated gene knockout and advanced cancer studies. This article distills experimental protocols, troubleshooting insights, and the translational bridge between immune profiling and genetic engineering, empowering researchers to leverage APExBIO’s high-purity Tamoxifen for reproducible, high-impact results.

• Latrunculin B Inhibitor: Precision Disruption of Actin Dynam

  2026-05-21

  Latrunculin B delivers rapid, reversible actin cytoskeleton disruption, enabling high-resolution studies of cellular actin dynamics. This guide translates bench-proven workflows and troubleshooting strategies, showing how APExBIO’s Latrunculin B unlocks robust, reproducible results in cytoskeletal research.

• Autophagy–Metastasis Signature Predicts CRC Prognosis and Im

  2026-05-21

  Bai et al. (2026) developed a novel prognostic signature for colorectal cancer (CRC) by integrating autophagy and liver metastasis-associated genes, leveraging both bulk and single-cell transcriptomic data. Their risk model provides improved predictive power for patient outcomes and offers mechanistic insight into how autophagy and metastasis contribute to immune evasion, with implications for therapy response and translational research.

• USP7 Modulates Macrophage Polarization via PKM2 in Pancreati

  2026-05-20

  This study uncovers how ubiquitin-specific protease 7 (USP7) regulates macrophage polarization through pyruvate kinase M2 (PKM2)-dependent metabolic reprogramming in severe acute pancreatitis. The findings highlight a novel immunometabolic axis that could be targeted to alleviate inflammation in pancreatitis and potentially other inflammatory conditions.

• MHY1485: Strategic mTOR Activation for Translational Discove

  2026-05-20

  This executive article guides translational researchers in leveraging MHY1485, a powerful mTOR activator and autophagy inhibitor, to dissect cell signaling and disease pathways. Integrating mechanistic insight, competitive positioning, and practical protocol advice, it synthesizes recent evidence—including findings on mTOR modulation in metabolic disease—to shape a forward-thinking research strategy.

• TAK-715: Redefining p38α MAPK Inhibition in Translational Re

  2026-05-19

  This article offers translational researchers a comprehensive perspective on TAK-715, a highly selective p38 MAPK inhibitor, emphasizing its dual-action mechanism, experimental best practices, and future impact on cytokine signaling modulation and anti-inflammatory agent development. By integrating mechanistic findings from recent structural studies with actionable protocol guidance, we outline how TAK-715—available from APExBIO—sets new benchmarks for specificity, efficacy, and translational potential in chronic inflammatory disease research.

• p53/PUMA-Dependent Lethality via WRN Inhibition in MSI Colon

  2026-05-19

  This study reveals that inhibition or loss of Werner (WRN) helicase induces p53/PUMA-mediated apoptosis selectively in mismatch repair-deficient (MSI) colorectal cancer cells. These findings clarify the molecular vulnerability of p53-wildtype MSI CRCs and highlight WRN as a promising synthetic lethality target for precision cancer therapies.

404 records 7/27 page Previous Next First page 上5页 678910 下5页 Last page